Generative AI vendors claim their software ‘learns’ from what it’s fed. Stanford researchers suggest training data gets ...

The fourth quarter was a big one for all of the major banks. Crossmark Global Investments chief market strategist Victoria ...

Ark's data shows bitcoin has weak price correlations with stocks, bonds, and gold, making it potentially attractive for ...

During his 2024 U.S. presidential run, then-candidate Donald Trump promised to establish a strategic bitcoin reserve if he ...

TheFly reported on January 9 that UBS analyst David Vogt maintained a Buy rating on SNX and raised the price target from $187 ...

Bitcoin price remained around $95,156 with minimal liquidation pressure as traders exhibited caution due to recent ...

GLP-1 drugs don’t just change what people eat,” Karthik Srinivasan, communications strategy consultant, tells Invezz. They ...

As of early 2026, the U.S. economy is in a fragile “stagflation-lite” phase, balancing resilient growth against an elevated risk of recession. According to major financial organizations like J.P.

As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

Bourse rises for fifth straight day – longest streak since May; Perseus confirms death at Cote d’Ivorie mine; Capstone Copper ...

The timing couldn’t have been more awkward for Thinking Machines Lab. On Wednesday, during an all-hands meeting at the AI ...

Boston Scientific, which is growing in Minnesota, is buying California’s Penumbra for $14.5 billion. CEO Mike Mahoney said ...